Core Viewpoint - A class action lawsuit has been filed against Pinterest, Inc. for allegedly misleading investors regarding its advertising revenue and the impact of U.S. tariffs on its business operations [1][2]. Group 1: Allegations and Financial Impact - The lawsuit claims that Pinterest failed to disclose reduced revenues from advertising partners and overstated its ability to manage the impact of U.S. tariffs on its business environment [2]. - The complaint indicates that the misleading statements were significant enough that Pinterest was facing or likely to face an imminent restructuring [2]. - On February 12, 2026, Pinterest reported quarterly revenue of $1.32 billion, which was below the consensus estimate of $1.33 billion, and provided Q1 2026 revenue guidance of $951 million to $971 million, also below the consensus estimate of $980.6 million [3]. Group 2: Stock Price Reaction - Following the announcement of disappointing financial results, Pinterest's stock price fell by $3.12 per share, or 16.83%, closing at $15.42 on February 13, 2026 [3]. Group 3: Class Action Participation - Shareholders wishing to serve as lead plaintiffs in the class action must file their papers with the court by May 29, 2026, but participation is not required to be eligible for recovery [4].

Core Viewpoint - A class action has been filed against Boston Scientific Corporation for allegedly misleading investors about its projected revenue and growth potential during the class period from July 23, 2025, to February 3, 2026 [1][2]. Group 1: Allegations and Market Impact - The complaint alleges that Boston Scientific misrepresented its revenue outlook and growth potential, downplaying risks from seasonality and macroeconomic factors [2]. - The company aimed to grow its share in the electrophysiology (EP) market at twice the market rate but faced new competition that negatively impacted its U.S. market share and growth potential [2]. - Following the announcement of disappointing fourth quarter and full year 2025 results, including poor U.S. EP sales and guidance for fiscal 2026 that was below expectations, Boston Scientific's stock price dropped over 17%, from $91.62 on February 3, 2026, to $75.50 on February 4, 2026 [3]. Group 2: Shareholder Actions - Shareholders may participate in the class action against Boston Scientific and those wishing to serve as lead plaintiff must submit their papers by May 4, 2026 [4]. - Shareholders are not required to participate in the case to be eligible for recovery and can remain absent class members if they choose [4]. Group 3: Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses for representation [5]. - The firm has a history of advocating for shareholder rights and aims to help recover losses and improve corporate governance [5].

Core Viewpoint - The Schall Law Firm is investigating potential breaches of fiduciary duty by the board of directors and management of Priority Technology Holdings, Inc. (NASDAQ: PRTH) on behalf of its investors [1][2]. Group 1: Investigation Details - The investigation aims to determine if the board of Priority Technology has violated its fiduciary responsibilities to shareholders [2]. - Shareholders are encouraged to participate in the investigation and can contact the Schall Law Firm for further discussion regarding their rights [2]. Group 2: Firm Background - The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors globally [3].

Core Viewpoint - The Super Micro Computer, Inc. is facing a class action lawsuit due to allegations of misleading statements and violations of U.S. export control laws related to significant sales to Chinese companies [4][5]. Group 1: Lawsuit Details - The class action lawsuit, titled Bhuva v. Super Micro Computer, Inc., aims to represent investors who purchased Super Micro securities and alleges violations of the Securities Exchange Act of 1934 [1]. - The lawsuit claims that Super Micro's sales to Chinese companies violated U.S. export control laws and that there were material weaknesses in the company's compliance controls [4]. - The U.S. Department of Justice announced an indictment against three individuals associated with Super Micro for diverting servers with U.S. AI technology to China, allegedly generating approximately $2.5 billion in sales from 2024 to 2025 [5]. Group 2: Financial Impact - Following the DOJ announcement regarding the indictment, Super Micro's stock price fell by more than 33% [5]. - The lawsuit allows any investor who suffered substantial losses during the class period to seek appointment as lead plaintiff, which is crucial for directing the class action [6]. Group 3: Legal Representation - Robbins Geller Rudman & Dowd LLP is leading the class action lawsuit and is recognized as a top law firm in securities fraud litigation, having recovered over $916 million for investors in 2025 alone [7].

Core Viewpoint - A class action has been filed against Power Solutions International, Inc. (PSIX) for allegedly misleading investors about its business prospects and financial performance during the specified period [1][2]. Allegations - The complaint alleges that Power Solutions overstated its ability to capture sales demand in the data center market and understated the impact of manufacturing capacity enhancements, leading to materially misleading statements about the company's operations and prospects [2]. - Specific allegations include the failure to disclose the expected costs and nature of inefficiencies related to production ramp-up for data center products [2]. Financial Performance - On March 2, 2026, Power Solutions announced its fourth quarter and full year 2025 financial results, revealing an 8% year-over-year decline in gross margin due to operating inefficiencies from accelerated production for data center products [3]. - The company projected only moderate margin improvement for 2026 and indicated that it was beginning to see measurable improvements in supply chain performance and manufacturing cost structures [3]. - Following the announcement, Power Solutions' stock price fell by $24.84, or 28.97%, closing at $60.91 on March 3, 2026 [3]. Class Action Participation - Shareholders interested in serving as lead plaintiffs must file their papers by May 19, 2026, and can remain absent class members if they choose not to participate [4].

Core Viewpoint - The Trip.com Group Limited is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements and failure to disclose regulatory risks associated with its monopolistic practices [1][4]. Company Overview - Trip.com operates as a travel service provider, offering services such as accommodation reservations, transportation ticketing, packaged tours, in-destination services, corporate travel management, and other travel-related services [3]. Allegations - The lawsuit alleges that during the class period, Trip.com and its executives made false or misleading statements and failed to disclose the regulatory risks stemming from their monopolistic business activities [4]. - A significant event occurred on January 14, 2026, when Bloomberg reported that China was investigating Trip.com for alleged antitrust conduct, which led to a 19% drop in the price of Trip.com American Depositary Shares over two trading sessions [5]. Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Trip.com securities during the class period to seek appointment as lead plaintiff in the lawsuit, representing the interests of all class members [6]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone, and a total of $8.4 billion over the past five years [7].

Core Viewpoint - A class action lawsuit has been filed against Apollo Global Management, Inc. for failing to disclose its connections with Jeffrey Epstein, which allegedly misled investors about the company's business and reputation [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from May 10, 2021, to February 21, 2026 [2]. - The allegations include that Apollo Global's leadership had frequent communications with Jeffrey Epstein regarding the company's business, contradicting their public statements that they had never done business with him [2]. Group 2: Stock Price Impact - Following the publication of articles detailing Epstein's involvement, Apollo Global's stock price fell significantly: - On February 2, 2026, the stock dropped by $1.35 to close at $133.19 [3]. - On February 3, 2026, it fell an additional $6.34 to close at $126.85 [3]. - On February 17, 2026, the stock dropped from $125.15 to $118.34, a decrease of $6.81 over two trading days [3]. - On February 23, 2026, the stock fell by $5.99, approximately 5%, to close at $113.73 [3]. Group 3: Shareholder Actions - Shareholders may participate in the class action and must submit their papers to the court by May 1, 2026, if they wish to serve as lead plaintiff [4]. - Shareholders can choose to remain absent from the case and still be eligible for recovery [4].

Core Viewpoint - Trip.com Group Limited is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements and failure to disclose regulatory risks associated with its monopolistic practices [4][5]. Company Overview - Trip.com operates as a travel service provider, offering services such as accommodation reservations, transportation ticketing, packaged tours, in-destination services, and corporate travel management [3]. Allegations - The lawsuit alleges that during the class period from April 30, 2024, to January 13, 2026, Trip.com and its executives made false statements and failed to disclose significant regulatory risks, particularly related to antitrust issues [4]. - A Bloomberg article published on January 14, 2026, reported that China is investigating Trip.com for alleged antitrust conduct, which led to a 19% drop in the price of Trip.com American Depositary Shares over two trading sessions [5]. Legal Process - Investors who purchased Trip.com securities during the class period can seek appointment as lead plaintiff in the class action lawsuit, which allows them to represent the interests of all class members [6]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [7].

Core Viewpoint - A class action lawsuit has been filed against Coty Inc. for allegedly misleading investors about its financial performance and growth outlook during the specified period [1][2]. Allegations - The lawsuit claims that Coty misrepresented its growth prospects through new product launches and operational improvements while downplaying risks associated with a slowing beauty market [2]. - It is alleged that the Consumer Beauty segment was underperforming, with compressed margins due to increased marketing investments and a decline in the Prestige fragrance market [2]. Financial Results - On February 4 and 5, 2026, Coty announced disappointing financial results for Q2 of fiscal year 2026, revealing worsening performance in the Consumer Beauty segment [3]. - The company also announced a leadership transition and withdrew its fiscal year 2026 EBITDA guidance, revising its near-term outlook downward due to macroeconomic factors and operational issues [3]. - Following the announcement, Coty's stock price fell from $3.43 per share to $2.66 per share, a decline of approximately 22% [3]. Class Action Participation - Shareholders interested in participating as lead plaintiffs must submit their papers by May 22, 2026, but they can remain absent class members if they choose not to take action [4]. Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses for representation [5].

Core Viewpoint - A class action lawsuit has been filed against Atara Biotherapeutics, Inc. for allegedly misleading investors regarding its drug candidate tabelecleucel, which is intended for treating certain cancers and autoimmune diseases [1][2]. Group 1: Allegations and Issues - The lawsuit claims that Atara failed to disclose significant manufacturing issues and deficiencies in the ALLELE study, which made FDA approval of tabelecleucel unlikely [2]. - It is alleged that the regulatory prospects of tabelecleucel were overstated, and the manufacturing issues increased the risk of regulatory scrutiny and jeopardized ongoing clinical trials [2]. - The complaint suggests that these undisclosed issues would likely have a significant negative impact on Atara's business and financial condition, rendering public statements materially false and misleading [2]. Group 2: Stock Price Impact - Following the announcement of a Complete Response Letter (CRL) from the FDA on January 12, 2026, Atara's stock price fell by $7.79 per share, or 56.99%, closing at $5.88 per share [3]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must submit their papers to the court by May 22, 2026, to serve as lead plaintiff, representing other class members [4]. - Shareholders can choose to remain absent from the case while still being eligible for recovery [4]. Group 4: Company Background - Atara Biotherapeutics, Inc. focuses on developing therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the U.S. and the U.K., with its lead product candidate being tabelecleucel [1].